BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1516594)

  • 1. Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of CaCO3 crystal growth.
    Verdier JM; Dussol B; Casanova P; Daudon M; Dupuy P; Berthezene P; Boistelle R; Berland Y; Dagorn JC
    Eur J Clin Invest; 1992 Jul; 22(7):469-74. PubMed ID: 1516594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal lithostathine: a new protein inhibitor of lithogenesis].
    Verdier JM; Dussol B; Casanova P; Daudon M; Dupuy P; Berthezène P; Boistelle R; Berland Y; Dagorn JC
    Nephrologie; 1993; 14(6):261-4. PubMed ID: 8145883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nucleation and crystal growth of calcium carbonate by human lithostathine.
    Bernard JP; Adrich Z; Montalto G; De Caro A; De Reggi M; Sarles H; Dagorn JC
    Gastroenterology; 1992 Oct; 103(4):1277-84. PubMed ID: 1397886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatic lithostathine inhibitor of calcium carbonate precipitation: structure-function relationship].
    Bernard JP; Takacs T; de Reggi M; Sarles H; Dagorn JC
    Nephrologie; 1993; 14(6):257-9. PubMed ID: 8145882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium carbonate crystals promote calcium oxalate crystallization by heterogeneous or epitaxial nucleation: possible involvement in the control of urinary lithogenesis.
    Geider S; Dussol B; Nitsche S; Veesler S; Berthézène P; Dupuy P; Astier JP; Boistelle R; Berland Y; Dagorn JC; Verdier JM
    Calcif Tissue Int; 1996 Jul; 59(1):33-7. PubMed ID: 8661982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic lithostathine as a calcite habit modifier.
    Geider S; Baronnet A; Cerini C; Nitsche S; Astier JP; Michel R; Boistelle R; Berland Y; Dagorn JC; Verdier JM
    J Biol Chem; 1996 Oct; 271(42):26302-6. PubMed ID: 8824282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human pancreatic stone protein.
    De Caro A; Multigner L; Dagorn JC; Sarles H
    Biochimie; 1988 Sep; 70(9):1209-14. PubMed ID: 3147713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth.
    De Caro A; Multigner L; Lafont H; Lombardo D; Sarles H
    Biochem J; 1984 Sep; 222(3):669-77. PubMed ID: 6487269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithostathine, an inhibitor of CaCO3 crystal growth in pancreatic juice, induces bacterial aggregation.
    Iovanna J; Frigerio JM; Dusetti N; Ramare F; Raibaud P; Dagorn JC
    Pancreas; 1993 Sep; 8(5):597-601. PubMed ID: 8302796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals.
    De Reggi M; Gharib B; Patard L; Stoven V
    J Biol Chem; 1998 Feb; 273(9):4967-71. PubMed ID: 9478942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor?
    Bimmler D; Graf R; Scheele GA; Frick TW
    J Biol Chem; 1997 Jan; 272(5):3073-82. PubMed ID: 9006958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibody analysis of human pancreatic juice components related to the pancreatic calculi protein].
    Montalto G; Lusher M; De Caro A; Multigner L; Sarles H; Delaage M
    C R Acad Sci III; 1985; 300(6):199-202. PubMed ID: 3919892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic matrix of pancreatic stones associated with nutritional pancreatitis.
    Montalto G; Multigner L; Sarles H; De Caro A
    Pancreas; 1988; 3(3):263-8. PubMed ID: 3387420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine.
    Gerbaud V; Pignol D; Loret E; Bertrand JA; Berland Y; Fontecilla-Camps JC; Canselier JP; Gabas N; Verdier JM
    J Biol Chem; 2000 Jan; 275(2):1057-64. PubMed ID: 10625646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immunoreactive pancreatic stone protein in pancreatic stone, pancreatic tissue, and pancreatic juice.
    Yamadera K; Moriyama T; Makino I
    Pancreas; 1990 May; 5(3):255-60. PubMed ID: 2111547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic stone protein, a new marker for chronic pancreatitis].
    Montalto G; Carroccio A; Notarbartolo A
    Minerva Med; 1988 Feb; 79(2):91-4. PubMed ID: 3352949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreatic lithogenesis].
    Sarles H
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):37-40. PubMed ID: 3963739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical localization of pancreatic stone protein in the human digestive tract.
    Lechene de la Porte P; de Caro A; Lafont H; Sarles H
    Pancreas; 1986; 1(4):301-8. PubMed ID: 3550781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of human lithostathine S2-5 forms using the antibody to the N-terminal peptide region.
    Yamadera K; Wada K; Goto M; Yokoyama K; Morita Y; Kitano Y; Makino I
    Pancreas; 1998 May; 16(4):475-80. PubMed ID: 9598807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic stone protein, a phosphoprotein which inhibits calcium carbonate precipitation from human pancreatic juice.
    Multigner L; De Caro A; Lombardo D; Campese D; Sarles H
    Biochem Biophys Res Commun; 1983 Jan; 110(1):69-74. PubMed ID: 6838525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.